bioAffinity Technologies Publishes Clinical White Paper Highlighting Practical Use of CyPath® Lung for Pulmonary Nodule Risk Assessment bioAffinity Technologies, Inc., a biotechnology company dedicated to advancing noninvasive diagnostics and early…
Spruce Biosciences Strengthens Executive Leadership with Appointment of Rare Disease Expert as Chief Medical Officer Spruce Biosciences, Inc., a late-stage biopharmaceutical company dedicated to developing innovative therapies for neurological disorders…
Enhanced Group Applauds FDA Advisory Committee Recommendation Supporting Regulated Access to Therapeutic Peptides Enhanced Group Inc. (NYSE: ENHA), a company focused on elite sports performance, personalized health optimization, and evidence-based…
Precision BioSciences Strengthens Executive Leadership to Support Clinical Growth and Advance Gene Editing Pipeline Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical-stage gene editing company focused on developing transformative in vivo…
Gossamer Bio Advances Toward NDA Submission for Seralutinib, Reacquires Global Rights, and Strengthens Strategic Position Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for…
Yarrow Bioscience Completes Merger with VYNE Therapeutics and Secures Approximately $200 Million to Advance First-in-Class Autoimmune Thyroid Disease Program Yarrow Bioscience, Inc., a clinical-stage biotechnology company dedicated to developing innovative…
Glaukos Completes Enrollment in Pivotal U.S. Study of PRESERFLO™ MicroShunt for Advanced Primary Open-Angle Glaucoma Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company dedicated to developing innovative treatments for…
Arcus Biosciences and Summit Therapeutics Collaborate to Advance Novel Combination Therapy for Advanced Kidney Cancer Arcus Biosciences, Inc., a clinical-stage global biopharmaceutical company focused on developing innovative therapies for cancer…
Aptar Pharma’s Nanopharm Facility Earns MHRA GMP Certification, Strengthening Global Support for Inhaled and Nasal Drug Development Aptar Pharma, a global leader in drug delivery systems, dosing technologies, protection solutions,…
GCCL and GemPharmatech Form Strategic Alliance to Deliver Integrated Drug Discovery and Clinical Development Solutions GCCL, a South Korea-based provider of clinical trial sample analysis and central laboratory services, and…
Cancer Cell Diagnostics Launches CellSight™ DNA Comprehensive Genomic Profiling Test to Advance Precision Oncology Cancer Cell Diagnostics (CCDx) has announced the commercial launch of CellSight™ DNA, its next-generation comprehensive genomic…
Kairos Pharma and Bayer Partner to Advance Combination Therapy for Metastatic Prostate Cancer Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company focused on developing therapies that overcome cancer drug resistance, has…